The Effect of Purgative Manna on the Infant Jaundice Jaundice treatment by purgative manna
Iranian Journal of Pharmaceutical Sciences,
Vol. 1 No. 2 (2005),
1 Farvardin 2005
,
Page 95-100
https://doi.org/10.22037/ijps.v1.39451
Abstract
Infant jaundice is observed during the first week of life in approximately 60% of term and 80% of preterm infants. Hyperbilirubinemia may lead to the development of kernicterus, hearing loss, and convulsion. The goal of therapy in hyperbilirubinemia is lowering blood bilirubin levels or at least preventing its increase. It is recommended that phototherapy and if unsuccessful, blood exchange transfusion be used to keep bilirubin in the normal levels. In the Iranian traditional medicine, Cotoneaster manna (purgative manna) is commonly used in the treatment of infant jaundice. However, no scientific data was available regarding its effectiveness. In this study, purgative manna which was obtained from Cotoneaster discolor Pojark from south eastern Iran was used as an oral drop preparation. After standardization of the manna and the drop, clinical study was performed on 200 hyperbilirubinemic newborns. The serum bilirubin was assayed twice a day, using spectrophotometric method. The results showed that 88% of the infants who were treated by purgative manna plus phototherapy were cured during the first 3 days of administration, but only 21% of the infants who were treatment by phototherapy alone were cured.
- Infant jaundice
- Bilirubin
- Cotoneaster
- Purgative manna
How to Cite
References
[2] Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin Perinatology 2004; 28: 326- 33.
[3] Maines MD. New developments in the regulation of heme metabolism and their implications. CritRev Toxicol 1984; 12: 241-314.
[4] Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. Semin Neonatal 2002; 7; 111–9.
[5] Rodgers PA, Stevenson DK. Developmental biology of heme oxygenase. Clin Prinatology 1990; 17(2): 275-91.
[6] Ennever JF. Blue light, green light, white light, more light: treatment of neonatal jaundice. Clin Perinatalogy 1990; 17(2): 467-82.
[7] Vert P. Physiopathology of neonatal hyperbilirubinemia. Arch Pediatr 1998; 5: 1028 – 30.
[8] De Vries LS, Lary S, Dubowitz LM. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. Pediatrics 1985; 76: 351-4.
[9] van de Bor M, van Zeben-van der Aa TM, Verloove-Vanhorick SP, Brand R, Ruys JH. Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: results of a national collaborative survey. Pediatrics 1989; 83(6) 915-20.
[10] Nelson WE, Behrman RE, Kliegman RM. Nelson text book of pediatrics. Philadelphia: WB Saunders Company 14th. ed., 1992; p. 467.
[11] Valaes T, Petmezaki S, Doxiadis SA. Prevention of neonatal jaundice. Iatriki 1973; 23: 244.
[12] Dennery PA, McDonagh AF, Spitz DR, Rogers PA, Stevenson DK. Hyperbilirubnemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia . Free Radic Biol Med 1995; 19: 395 – 404.
[13] Amine G. Iranian medicinal plants and traditional drugs. Tehran: Farhang Press, 1991; PP. 143 – 4.
[14] Khatamsaz M. Flora of Iran, number 6. Rosaceae family. Tehran: Research institute of forests and rangelands, 1992; PP. 229-31.
[15] Bhandarkar MR, Khan A. Antihepatotoxic effect of Nymphaea stellata Wild. against carbon tetrachloride-induced hepatic damage in albino rats. J Ethnopharmacol 2004; 91: 61-4.
[16] Rajesh MG, Latha MS. Preliminary evaluation of the antihepatotoxic activity of Kamilari, a polyherbal formulation. J Ethnopharmacol 2004; 91: 99-104.
- Abstract Viewed: 327 times
- IJPS_Volume 1_Issue 2_Pages 95-100 Downloaded: 276 times